In a recent clinical trial, researchers compared therapeutic drug monitoring during maintenance infliximab therapy with standard treatment. Which therapy was more likely to lead to sustained disease control among patients with immune-mediated...
In a recent clinical trial, researchers compared therapeutic drug monitoring during maintenance infliximab therapy with standard treatment. Which therapy was more likely to lead to sustained disease control among patients with immune-mediated...
In a recent clinical trial,...